The radiosensitizing effect of fluorocyclopentenyl-cytosine (RX-3117) in ovarian and lung cancer cell lines

被引：3
|
作者：
Sarkisjan, Dzjemma [1 ]
van den Berg, Jaap [2 ]
Smit, Evelyn [1 ]
Lee, Young B. [3 ]
Kim, Deog J. [3 ]
Peters, Godefridus J. [1 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Dept Radio Therapy, Amsterdam, Netherlands
[3] Rexahn Pharmaceut Inc, Rockville, MD USA
来源：
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 2016年 / 35卷 / 10-12期
关键词：
RX-3117; cytidine analog; radiosensitizing effect; DNA damage; cell cycle proteins; GROWTH-FACTOR RECEPTOR; CHEMOTHERAPEUTIC-AGENTS; ANTITUMOR-ACTIVITY; IN-VIVO; GEMCITABINE; AZACITIDINE; MECHANISM; DNA; 2'; 2'-DIFLUORO-2'-DEOXYCYTIDINE; 5-AZACYTIDINE;
D O I：
10.1080/15257770.2016.1216565
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
RX-3117 (fluorocyclopentenyl-cytosine) is a novel cytidine analog currently being evaluated in a Phase Ib clinical trial in cancer patients with solid tumors. The radiosensitizing effect of RX-3117 was studied in A2780 ovarian cancer cells and non-small cell lung cancer cell lines and related to cell survival and the effect on cell cycle and cell cycle proteins. RX-3117 has a schedule-dependent radiosensitizing effect, but only at pre-incubation (dose modifying factors: 1.4-1.8), observed at pulse and fractionated irradiation. Radiosensitizion was also seen in a three-dimensional spheroid model. At the low radiosensitizing concentration, RX-3117 in combination with radiation led to an accumulation of cells in S-phase, which was accompanied with an increase of cell cycle proteins such as p-Chk2 and p-cdc25C. In addition, RX-3117 caused DNA damage and increased apoptosis. In conclusion, our in vitro experiments showed a radiosensitizing effect of RX-3117.
引用
收藏
页码：619 / 630
页数：12
相关论文
共 50 条
  • [21] Radiosensitizing Effect of Novel Phenylpyrimidine Derivatives on Human Lung Cancer Cells via Cell Cycle Perturbation
    Jung, Seung-Youn
    Nam, Ky-Youb
    Park, Jeong-In
    Song, Kyung-Hee
    Ahn, Jiyeon
    Park, Jong Kuk
    Urn, Hong-Duck
    Hwang, Sang-Gu
    Choi, Sang Un
    Song, Jie-Young
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2019, 370 (03): : 514 - 527
  • [22] In vivo study of radiosensitizing effect of hypoxic cell radiosensitizer PR-350 on a human small cell lung cancer
    Suzuki, Y
    Hasegawa, M
    Hayakawa, K
    Mitsuhashi, N
    Niibe, H
    ANTICANCER RESEARCH, 1999, 19 (5B) : 3993 - 4000
  • [23] Arginase activity in ovarian cancer cell lines:: effect of interferon-γ treatment
    Melichar, B
    Patenia, R
    Melicharova, K
    Freedman, RS
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 134 - 135
  • [24] DHMEQ enhances the cytotoxic effect of cisplatin and carboplatin in ovarian cancer cell lines
    Michalak, Marcin
    Lach, Michel S.
    Borska, Sylwia
    Nowakowski, Blazej
    Umezawa, Kazuo
    Suchorska, Wiktoria M.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (12): : 6024 - 6041
  • [25] Effect of Gefitinib on EGFR activation in lung cancer cell lines.
    Salimi-Moosavi, H
    Jin, XG
    Badal, Y
    Tian, T
    Wei, J
    Samain, C
    Tahir, H
    Kirakossian, H
    Singh, S
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8994S - 8994S
  • [26] Effect of vesnarinone in combination with anti-cancer drugs on lung cancer cell lines
    Fujita, M
    Tsuchida, T
    Higashino, K
    ANTI-CANCER DRUGS, 1999, 10 (01) : 119 - 127
  • [27] Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell lines
    van Moorsel, CJA
    Pinedo, HM
    Veerman, G
    Guechev, A
    Smid, K
    Loves, WJP
    Vermorken, JB
    Postmus, PE
    Peters, GJ
    BIOCHEMICAL PHARMACOLOGY, 1999, 57 (04) : 407 - 415
  • [28] Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines
    van Moorsel, CJA
    Pinedo, HM
    Veerman, G
    Bergman, AM
    Kuiper, CM
    Vermorken, JB
    van der Vijgh, WJF
    Peters, GJ
    BRITISH JOURNAL OF CANCER, 1999, 80 (07) : 981 - 990
  • [29] Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines
    C J A van Moorsel
    H M Pinedo
    G Veerman
    A M Bergman
    C M Kuiper
    J B Vermorken
    W J F van der Vijgh
    G J Peters
    British Journal of Cancer, 1999, 80 : 981 - 990
  • [30] Metformin Impairs Linsitinib Anti-Tumor Effect on Ovarian Cancer Cell Lines
    Almeida-Nunes, Diana Luisa
    Silva, Joao P. N.
    Nunes, Mariana
    Silva, Patricia M. A.
    Silvestre, Ricardo
    Dinis-Oliveira, Ricardo Jorge
    Bousbaa, Hassan
    Ricardo, Sara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (22)
12345